336 related articles for article (PubMed ID: 32079590)
1. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
[TBL] [Abstract][Full Text] [Related]
3. Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
Verma R; Correa R; Hill VB; Statsevych V; Bera K; Beig N; Mahammedi A; Madabhushi A; Ahluwalia M; Tiwari P
Radiol Artif Intell; 2020 Nov; 2(6):e190168. PubMed ID: 33330847
[TBL] [Abstract][Full Text] [Related]
4. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
[TBL] [Abstract][Full Text] [Related]
5. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
6. Stable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study.
Verma R; Hill VB; Statsevych V; Bera K; Correa R; Leo P; Ahluwalia M; Madabhushi A; Tiwari P
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1115-1123. PubMed ID: 36920774
[TBL] [Abstract][Full Text] [Related]
7. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
Beig N; Singh S; Bera K; Prasanna P; Singh G; Chen J; Saeed Bamashmos A; Barnett A; Hunter K; Statsevych V; Hill VB; Varadan V; Madabhushi A; Ahluwalia MS; Tiwari P
Neuro Oncol; 2021 Feb; 23(2):251-263. PubMed ID: 33068415
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
9. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.
Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B
IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848
[TBL] [Abstract][Full Text] [Related]
10. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
[TBL] [Abstract][Full Text] [Related]
12. Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma.
Guan F; Wang Z; Qiu Y; Guo Y; Pei D; Wang M; Xing A; Liu Z; Yu B; Cheng J; Liu X; Ji Y; Yan D; Yan J; Zhang Z
J Transl Med; 2023 Nov; 21(1):841. PubMed ID: 37993907
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging and deoxyribonucleic acid methylation-based radiogenomic models for survival risk stratification of glioblastoma.
Zhang W; Yan Z; Peng J; Zhao S; Ran L; Yin H; Zhong D; Yang J; Ye J; Xu S
Med Biol Eng Comput; 2024 Mar; 62(3):853-864. PubMed ID: 38057447
[TBL] [Abstract][Full Text] [Related]
14. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
[TBL] [Abstract][Full Text] [Related]
15. Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.
Fathi Kazerooni A; Akbari H; Shukla G; Badve C; Rudie JD; Sako C; Rathore S; Bakas S; Pati S; Singh A; Bergman M; Ha SM; Kontos D; Nasrallah M; Bagley SJ; Lustig RA; O'Rourke DM; Sloan AE; Barnholtz-Sloan JS; Mohan S; Bilello M; Davatzikos C
JCO Clin Cancer Inform; 2020 Mar; 4():234-244. PubMed ID: 32191542
[TBL] [Abstract][Full Text] [Related]
16. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
[TBL] [Abstract][Full Text] [Related]
17. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
18. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
[TBL] [Abstract][Full Text] [Related]
19. The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis.
Liu Y; Zhang X; Feng N; Yin L; He Y; Xu X; Lu H
Acta Radiol; 2018 Oct; 59(10):1239-1246. PubMed ID: 29430935
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
